Intensive glucose control increased mortality and did not prevent cardiovascular events in type 2 diabetes
R P Byington
Dr R P Byington, Wake Forest University School of Medicine, Winston-Salem, NC, USA; bbyingto@wfubmc.edu
QUESTION
In patients with type 2 diabetes and cardiovascular disease or risk factors, does intensive glucose control prevent cardiovascular events more than standard glucose control?
METHODS
Design:
randomised controlled trial (Action to Control Cardiovascular Risk in Diabetes [ACCORD]).
Allocation:
concealed.
Blinding:
blinded (outcome adjudication committee and …
